LitAlert ~~

    • Association of Rare Pathogenic DNA Variants for Familial Hypercholesterolemia, Hereditary Breast and Ovarian Cancer Syndrome, and Lynch Syndrome With Disease Risk in Adults According to Family History.
    • Patel AP, Wang M, Fahed AC, Mason-Suares H, Brockman D, Pelletier R, Amr S, Machini K, Hawley M, Witkowski L, Koch C, Philippakis A, Cassa CA, Ellinor PT, Kathiresan S, Ng K, Lebo M, Khera AV.
    • JAMA Netw Open. 2020 Apr 29;3(4):e203959. doi: 10.1001/jamanetworkopen.2020.3959.
    • Olaparib for Metastatic Castration-Resistant Prostate Cancer.
    • de Bono J, Mateo J, Fizazi K, Saad F, Shore N, Sandhu S, Chi KN, Sartor O, Agarwal N, Olmos D, Thiery-Vuillemin A, Twardowski P, Mehra N, Goessl C, Kang J, Burgents J, Wu W, Kohlmann A, Adelman CA, Hussain M.
    • N Engl J Med. 2020 Apr 28. doi: 10.1056/NEJMoa1911440. [Epub ahead of print]
    • ASO Author Reflections: Pancreatic Cancer Patients with Germline BRCA Mutations Benefit from Early Introduction of Platinum-Based Chemotherapy.
    • Golan T, Barenboim A, Lubezky N.
    • Ann Surg Oncol. 2020 Apr 27. doi: 10.1245/s10434-020-08495-6. [Epub ahead of print]
    • Research review, Commentary

    Original research:

    Increased Rate of Complete Pathologic Response After Neoadjuvant FOLFIRINOX for BRCA Mutation Carriers with Borderline Resectable Pancreatic Cancer.

    • The Association Between Clinicopathological Features and Molecular Markers in Bahraini Women With Breast Cancer.
    • AlZaman A, Ali E, Mohamad B, Islam M, AlZaman E, AlZaman Y.
    • Gulf J Oncolog. 2020 Jan;1(32):19-25.